PMA device
Biosense Webster Cables
Biosense Webster, Inc. · Cardiac Ablation Percutaneous Catheter (LPB, Class III) · First FDA decision Dec 17, 2015, newest Sep 22, 2021Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
0
Naming "Webster Cables"
MAUDE reports
0
Brand "Webster Cables", since 2015
PubMed studies
0
Mentioning "Webster Cables"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Biosense Webster Cables
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- Biosense Webster CablesPMA supplement
P990071-S052 · Decided Sep 22, 2021 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- BIOSENSE WEBSTER CABLESPMA supplement
P990071-S034 · Decided Aug 10, 2017 · 423 days after receipt · Normal 180 Day Track
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- BIOSENSE WEBSTER CABLESPMA supplement
P990071-S028 · Decided Dec 17, 2015 · 533 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Webster Cables", any status and sponsor, newest update first.
No registered device study names "Webster Cables".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Webster Cables", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LPB
14,593 reports: 5,424 malfunction, 8,535 injury, 628 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0058-2018 · Started Sep 6, 2017
Reason given: Biosense Webster, Inc. has recently received an increased number of complaints related to the display of Alert 402 on the CARTO 3 System for certain lots of THERMOCOOL brand catheters. Alert 402 implies a "Map: magnetic distortion" when connected to CARTO 3 System. This issue may subsequently lead the physician to...
Cause as FDA categorized it: Under Investigation by firm · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-3178-2011 · Started Jul 7, 2011 · Posted by FDA Sep 12, 2011
Reason given: Biosense Webster has initiated a voluntary field notification to all customers that have a Stockert 70 Radio Frequency Generator, to communicate undetected software anomalies in the form of software release note in order to amend the labeling and thereby enhance the safety of the product.
Cause as FDA categorized it: Software design (manufacturing process) · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-0369-2010 · Started Oct 2, 2008 · Posted by FDA Nov 19, 2009
Reason given: Biosense Webster initiated the recall because of the potential concern with one of the Printed Circuit Board (PCB) components used in the NaviStar RMT Catheters, which may cause the ablation catheter icon to shift on the map viewer when RF energy is being applied. Therefore the user, attempting a linear ablation in...
Cause as FDA categorized it: Process control · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Webster Cables"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LPB.
- Therapy Ablation Catheter (4mm and 8mm)Irvine Biomedical, Inc. · PMA 2022
- Navistar ThermocoolBiosense Webster, Inc. · PMA 2014
- EZ Steer ThermoCool CatheterBiosense Webster, Inc. · PMA 2021
- Chilli II Cooled Ablation Catheter and CableBoston Scientific Corp · PMA 2020
- Livewire Tc Ablation Catheter, Safire Ablation CatheterSt Jude Medical · PMA 2016
- Chilli Cooled Ablation SystemBoston Scientific Corp · PMA 2011
- Blazer II Cardiac Ablation System and CableBoston Scientific Corp · PMA 2025
- Freezor Cardiac Cryoablation CatheterMedtronic Cryocath, LP · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.